• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1991 年至 2016 年期间,苏格兰首次急性心肌梗死患者心力衰竭住院风险降低。

Declining risk of heart failure hospitalization following first acute myocardial infarction in Scotland between 1991-2016.

机构信息

BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.

Public Health Scotland, Edinburgh, UK.

出版信息

Eur J Heart Fail. 2023 Aug;25(8):1213-1224. doi: 10.1002/ejhf.2965. Epub 2023 Jul 17.

DOI:10.1002/ejhf.2965
PMID:37401485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10946471/
Abstract

AIM

Mortality from acute myocardial infarction (AMI) has declined, increasing the pool of survivors at risk of later development of heart failure (HF). However, coronary reperfusion limits infarct size and secondary prevention therapies have improved. In light of these competing influences, we examined long-term trends in the risk of HF hospitalization (HFH) following a first AMI occurring in Scotland over 25 years.

METHODS AND RESULTS

All patients in Scotland discharged alive after a first AMI between 1991 and 2015 were followed until a first HFH or death until the end of 2016 (minimum follow-up 1 year, maximum 26 years). A total of 175 672 people with no prior history of HF were discharged alive after a first AMI during the period of study. A total of 21 445 (12.2%) patients had a first HFH during a median follow-up of 6.7 years. Incidence of HFH (per 1000 person-years) at 1 year following discharge from a first AMI decreased from 59.3 (95% confidence interval [CI] 54.2-64.7) in 1991 to 31.3 (95% CI 27.3-35.8) in 2015, with consistent trends seen for HF occurring within 5 and 10 years. Accounting for the competing risk of death, the adjusted risk of HFH at 1 year after discharge decreased by 53% (95% CI 45-60%), with similar decreases at 5 and 10 years.

CONCLUSION

The incidence of HFH following AMI in Scotland has decreased since 1991. These trends suggest that better treatment of AMI and secondary prevention are having an impact on the risk of HF at a population level.

摘要

目的

急性心肌梗死(AMI)的死亡率已经下降,这增加了那些以后可能发展为心力衰竭(HF)的幸存者的数量。然而,冠状动脉再灌注限制了梗塞面积,并且二级预防治疗也得到了改善。鉴于这些相互竞争的影响,我们研究了在苏格兰 25 年间首次发生 AMI 后 HF 住院(HFH)风险的长期趋势。

方法和结果

在 1991 年至 2015 年间首次 AMI 存活出院的所有苏格兰患者均进行了随访,直至首次 HFH 或死亡,直至 2016 年底(最低随访 1 年,最长 26 年)。在研究期间,共有 175672 名无 HF 既往史的患者首次 AMI 存活出院。在中位随访 6.7 年期间,共有 21445 名(12.2%)患者首次发生 HFH。首次 AMI 出院后 1 年时 HFH 的发生率(每 1000 人年)从 1991 年的 59.3(95%置信区间[CI] 54.2-64.7)下降到 2015 年的 31.3(95%CI 27.3-35.8),5 年和 10 年内的趋势一致。考虑到死亡的竞争风险,出院后 1 年时 HFH 的调整风险降低了 53%(95%CI 45-60%),5 年和 10 年时的风险也降低了。

结论

自 1991 年以来,苏格兰 AMI 后 HFH 的发生率有所下降。这些趋势表明,AMI 的治疗和二级预防的改善正在对人群水平的 HF 风险产生影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c828/10946471/fd228060549e/EJHF-25-1213-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c828/10946471/c0ed4f1616fa/EJHF-25-1213-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c828/10946471/ea699a37880b/EJHF-25-1213-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c828/10946471/faf8f0bd1521/EJHF-25-1213-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c828/10946471/fd228060549e/EJHF-25-1213-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c828/10946471/c0ed4f1616fa/EJHF-25-1213-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c828/10946471/ea699a37880b/EJHF-25-1213-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c828/10946471/faf8f0bd1521/EJHF-25-1213-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c828/10946471/fd228060549e/EJHF-25-1213-g001.jpg

相似文献

1
Declining risk of heart failure hospitalization following first acute myocardial infarction in Scotland between 1991-2016.1991 年至 2016 年期间,苏格兰首次急性心肌梗死患者心力衰竭住院风险降低。
Eur J Heart Fail. 2023 Aug;25(8):1213-1224. doi: 10.1002/ejhf.2965. Epub 2023 Jul 17.
2
Long-term impact of new-onset atrial fibrillation complicating acute myocardial infarction on heart failure.新发房颤合并急性心肌梗死对心力衰竭的长期影响。
ESC Heart Fail. 2020 Oct;7(5):2762-2772. doi: 10.1002/ehf2.12872. Epub 2020 Jun 23.
3
Risk Factors and Trends in Incidence of Heart Failure Following Acute Myocardial Infarction.心梗后心力衰竭发病的风险因素和趋势。
Am J Cardiol. 2018 Jul 1;122(1):1-5. doi: 10.1016/j.amjcard.2018.03.005. Epub 2018 Mar 28.
4
National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998-2010.美国医疗保险受益人心梗后心力衰竭住院的全国趋势:1998-2010 年。
Circulation. 2013 Dec 17;128(24):2577-84. doi: 10.1161/CIRCULATIONAHA.113.003668. Epub 2013 Nov 4.
5
Trends from 1996 to 2007 in incidence and mortality outcomes of heart failure after acute myocardial infarction: a population-based study of 20,812 patients with first acute myocardial infarction in Western Australia.1996 年至 2007 年急性心肌梗死后心力衰竭发病和死亡结局的趋势:对西澳大利亚 20812 例首次急性心肌梗死患者的基于人群的研究。
J Am Heart Assoc. 2013 Oct 8;2(5):e000172. doi: 10.1161/JAHA.113.000172.
6
Readmission and Mortality After Hospitalization for Myocardial Infarction and Heart Failure.心肌梗死和心力衰竭住院后的再入院和死亡率。
J Am Coll Cardiol. 2020 Feb 25;75(7):736-746. doi: 10.1016/j.jacc.2019.12.026.
7
Heart failure re-hospitalizations and subsequent fatal events in coronary artery disease: insights from COMMANDER-HF, EPHESUS, and EXAMINE.心力衰竭再住院和随后的冠心病致命事件:COMMANDER-HF、EPHESUS 和 EXAMINE 的见解。
Clin Res Cardiol. 2021 Oct;110(10):1554-1563. doi: 10.1007/s00392-021-01830-1. Epub 2021 Mar 8.
8
Prognostic Impact of In-Hospital and Postdischarge Heart Failure in Patients With Acute Myocardial Infarction: A Nationwide Analysis Using Data From the Cardiovascular Disease in Norway (CVDNOR) Project.急性心肌梗死患者住院期间及出院后心力衰竭的预后影响:一项基于挪威心血管疾病(CVDNOR)项目数据的全国性分析。
J Am Heart Assoc. 2017 Mar 15;6(3):e005277. doi: 10.1161/JAHA.116.005277.
9
Higher education is associated with reduced risk of heart failure among patients with acute myocardial infarction: A nationwide analysis using data from the CVDNOR project.高等教育与急性心肌梗死患者心力衰竭风险降低相关:一项使用CVDNOR项目数据的全国性分析。
Eur J Prev Cardiol. 2016 Nov;23(16):1743-1750. doi: 10.1177/2047487316655910. Epub 2016 Jul 19.
10
Trends in incidence and case fatality of acute myocardial infarction, angina and coronary revascularisation in people with and without type 2 diabetes in Scotland between 2006 and 2015.2006 年至 2015 年期间苏格兰有和无 2 型糖尿病患者的急性心肌梗死、心绞痛和冠状动脉血运重建发病率和病死率趋势。
Diabetologia. 2019 Mar;62(3):418-425. doi: 10.1007/s00125-018-4796-7. Epub 2019 Jan 17.

引用本文的文献

1
as a key regulator of myocardial infarction-to-heart failure transition revealed by multi-omics integration.作为多组学整合揭示的心肌梗死向心力衰竭转变的关键调节因子。
Front Genet. 2025 Jun 23;16:1592985. doi: 10.3389/fgene.2025.1592985. eCollection 2025.
2
RAB7 protects against ischemic heart failure via promoting non-canonical TUFM mitophagy pathway.RAB7通过促进非经典的TUFM线粒体自噬途径预防缺血性心力衰竭。
Theranostics. 2025 Jun 9;15(14):6753-6767. doi: 10.7150/thno.104124. eCollection 2025.
3
15-Year trends, predictors, and outcomes of heart failure hospitalization complicating first acute myocardial infarction in the modern percutaneous coronary intervention era.

本文引用的文献

1
Sacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win-ratio analysis of the PARADISE-MI trial.沙库巴曲缬沙坦对比雷米普利用于急性心肌梗死患者:PARADISE-MI 试验的优效性分析。
Eur J Heart Fail. 2022 Oct;24(10):1918-1927. doi: 10.1002/ejhf.2663. Epub 2022 Sep 14.
2
Evaluating the Application of Chronic Heart Failure Therapies and Developing Treatments in Individuals With Recent Myocardial Infarction: A Review.评估慢性心力衰竭治疗方法在近期心肌梗死患者中的应用及开发相关治疗方案:综述。
JAMA Cardiol. 2022 Oct 1;7(10):1067-1075. doi: 10.1001/jamacardio.2022.2847.
3
Empagliflozin in acute myocardial infarction: the EMMY trial.
现代经皮冠状动脉介入治疗时代首次急性心肌梗死并发心力衰竭住院的15年趋势、预测因素及结局
Eur Heart J Open. 2025 Feb 19;5(2):oeaf013. doi: 10.1093/ehjopen/oeaf013. eCollection 2025 Mar.
4
Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI).恩格列净预防心肌梗死后左心室容积和收缩功能恶化(EMPRESS-MI研究)
Eur J Heart Fail. 2025 Mar;27(3):566-576. doi: 10.1002/ejhf.3560. Epub 2024 Dec 15.
5
Heart failure treatment in the last years of life: A nationwide study of 364 000 individuals.生命最后几年的心力衰竭治疗:一项针对36.4万人的全国性研究。
Eur J Heart Fail. 2024 Nov;26(11):2443-2450. doi: 10.1002/ejhf.3426. Epub 2024 Aug 31.
6
Predictive value of initial Lp-PLA2, NT-proBNP, and peripheral blood-related ratios for heart failure after early onset infarction in patients with acute myocardial infarction.急性心肌梗死患者早期发病梗死后,初始脂蛋白相关磷脂酶A2、N末端B型脑钠肽原及外周血相关比值对心力衰竭的预测价值。
Am J Transl Res. 2024 Jul 15;16(7):2940-2952. doi: 10.62347/GSBB6486. eCollection 2024.
7
Global epidemiology of heart failure.心力衰竭的全球流行病学。
Nat Rev Cardiol. 2024 Oct;21(10):717-734. doi: 10.1038/s41569-024-01046-6. Epub 2024 Jun 26.
8
2024 update in heart failure.2024年心力衰竭治疗进展
ESC Heart Fail. 2025 Feb;12(1):8-42. doi: 10.1002/ehf2.14857. Epub 2024 May 28.
9
Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design.恩格列净预防心肌梗死后进行性不良重构(EMPRESS-MI):原理与设计。
ESC Heart Fail. 2024 Aug;11(4):2001-2012. doi: 10.1002/ehf2.14830. Epub 2024 May 7.
恩格列净治疗急性心肌梗死:EMMY 试验。
Eur Heart J. 2022 Nov 1;43(41):4421-4432. doi: 10.1093/eurheartj/ehac494.
4
Temporal trends in major cardiovascular events following first-time myocardial infarction in the reperfusion era - a Danish nationwide cohort study from 2000 to 2017.再灌注时代首次心肌梗死后主要心血管事件的时间趋势——一项2000年至2017年丹麦全国队列研究
Eur Heart J Qual Care Clin Outcomes. 2023 Apr 26;9(3):268-280. doi: 10.1093/ehjqcco/qcac033.
5
Heart Failure After ST-Elevation Myocardial Infarction: Beyond Left Ventricular Adverse Remodeling.ST 段抬高型心肌梗死后的心力衰竭:超越左心室不良重构。
Curr Probl Cardiol. 2023 Aug;48(8):101215. doi: 10.1016/j.cpcardiol.2022.101215. Epub 2022 Apr 20.
6
The growing importance of heart failure in myocardial infarction.心力衰竭在心肌梗死中的重要性日益增加。
Int J Cardiol. 2022 Apr 1;352:100-101. doi: 10.1016/j.ijcard.2022.01.068. Epub 2022 Feb 5.
7
Development and validation of an artificial neural network algorithm to predict mortality and admission to hospital for heart failure after myocardial infarction: a nationwide population-based study.开发和验证一种用于预测心肌梗死后心力衰竭患者死亡率和住院的人工神经网络算法:一项全国范围内基于人群的研究。
Lancet Digit Health. 2022 Jan;4(1):e37-e45. doi: 10.1016/S2589-7500(21)00228-4.
8
Impact of age, gender and heart failure on mortality trends after acute myocardial infarction in Italy.意大利急性心肌梗死后,年龄、性别和心力衰竭对死亡率趋势的影响。
Int J Cardiol. 2022 Feb 1;348:147-151. doi: 10.1016/j.ijcard.2021.12.023. Epub 2021 Dec 16.
9
Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial.沙库巴曲缬沙坦与雷米普利对PARADISE-MI试验中总体心力衰竭事件的影响。
Circulation. 2022 Jan 4;145(1):87-89. doi: 10.1161/CIRCULATIONAHA.121.057429. Epub 2021 Nov 19.
10
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.血管紧张素受体-脑啡肽酶抑制剂在急性心肌梗死中的应用。
N Engl J Med. 2021 Nov 11;385(20):1845-1855. doi: 10.1056/NEJMoa2104508.